Get more information on Topical Drug Delivery Market - Request Sample Report
The Topical Drug Delivery Market Size was valued at USD 210.03 Billion in 2023 and is expected to reach USD 499.39 Billion by 2032 and grow at a CAGR of 10.62% over the forecast period 2024-2032.
The distribution of medications through topical routes such as the skin, mucosa, or cavities in the body is referred to as topical drug delivery. These are used locally to avoid the drug's first-pass effect or for site-specific activity. Creams, foams, lotions, gels, ointments, and other drugs are included.
A topical mode of delivery provides advantages such as site-specificity, elimination of variations in drug levels, greater suitability for self-medication, and improved compliance. The pharmacological response of a drug, both the desired therapeutic effect and the undesirable adverse consequence, is determined by the concentration of the drug at the site of action, which is determined by the dose form and the amount of drug absorption at the site of action.
KEY DRIVERS:
The use of topical prescription medication for dry eye disorders is extremely common.
Transdermal patches are replacing traditional needle injections.
RESTRAINTS:
Topical medicines cause chronic skin irritation and allergies.
Preference for alternate drug delivery methods
OPPORTUNITY:
Self-administration and home care are becoming increasingly popular.
Biologics are delivered transdermally and Cosmetic industry uses topical vehicles
CHALLENGES:
Topical preparations for medicines with low plasma concentrations
The incidence of medicine failures and product recalls is increasing.
During the COVID-19 pandemic wave, self-medication was a frequent tendency for drug consumption. Many treatment facilities and single doctor clinics were closed as a result of the epidemic, depriving the general public of timely medical aid. The pandemic has prompted people to self-medicate. The most often utilised therapeutic techniques for self-medication were topical corticosteroids. Anti-acne preparations, corticosteroids, combos (corticosteroids, antibiotics, and antifungals), moisturisers, and barrier creams were the most commonly utilised topical medications. Self-medication has increased demand for over-the-counter and topical medications, which has benefited the topical drug delivery business.
One of the most common symptoms of COVID-19 was a runny nose, cold, and cough. Nasal sprays were beneficial in relieving nasal congestion during COVID-19. Amcyte Pharma, for example, introduced its Nasitrol nasal spray (topical solution) for sinus irrigation. The nasal cavity and rhino pharynx were the primary sites of SARS-CoV-2 propagation. The spray is designed to lower viral load in the upper respiratory tract, stopping viruses from multiplying and migrating into the lungs. This increase in nasal sprays that can decrease viral load during COVID-19 has raised demand for topical sprays and foams used to treat virus-induced nasal congestion.
The topical medication delivery market is divided into semi-solid formulations, liquid formulations, solid formulations, and transdermal products based on product. The semi-solid formulations segment held the greatest market share in 2021. This segment's substantial share is related to the applicability of APIs with low density, which are more stable in atmospheric conditions than liquid and solid forms, and the rise in personalised medicine due to their unique composition and increased absorptive capabilities. These dose forms are not dehydrating and have no effect on skin function.
The market is divided into five sections based on the method of administration: cutaneous, ophthalmic, rectal, vaginal, and nasal drug delivery. The dermal drug delivery market segment's large share can be attributed largely to pain-free self-administration for patients, which is advantageous for drugs with shorter half-lives or narrow therapeutic indices, as well as the elimination of frequent administration of drugs and plasma level peaks and valleys associated with oral dosing and injections to maintain a constant drug concentration.
The market is divided into home care settings, hospitals & clinics, burn centres, and other facilities based on the facility of usage. The high proportion of home care settings can be ascribed to benefits for long-term therapy, greater convenience over inpatient care, and improvements in medical adherence and treatment outcomes. Other key factors impacting the growth of the home care settings sector are the world's growing geriatric population and the growing requirement for self-administration of pharmaceuticals.
by Product
Semi-Solid Formulations
Liquid Formulations
Solid Formulations
Transdermal Products
by Route of Administration
Dermal Drug Delivery
Ophthalmic Drug Delivery
Rectal Drug Delivery
Vaginal Drug Delivery
Nasal Drug Delivery
by Facility of Use
Home Care Settings
Hospitals & Clinics
Burn Centers
Other Facilities
North America led the topical drug delivery market, followed by Europe, Asia Pacific, Latin America, and the Middle East and Africa. The rising prevalence of target health conditions, the increasing preference for pain-free drug delivery solutions, the rising prevalence of skin diseases, an increasing number of smokers worldwide, rising advancements in transdermal patches, and the high demand for drugs that can be self-administered all contribute to North America's large share.
Need any customization research on Topical Drug Delivery Market - Enquiry Now
REGIONAL COVERAGE:
North America
USA
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Rest of Europe
Asia-Pacific
Japan
south Korea
China
India
Australia
Rest of Asia-Pacific
The Middle East & Africa
Israel
UAE
South Africa
Rest of Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America
The Major players are Valeant Pharmaceuticals International, Inc., Crescita Therapeutics Inc., MedPharm Group Ltd., 3M Company, Bayer AG, Novartis AG, Janssen Global Services, LLC, and Cipla, Galderma S.A., GlaxoSmithKline plc. and other players.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | US$ 210.03 Billion |
| Market Size by 2032 | US$ 499.39 Billion |
| CAGR | CAGR of 10.62% From 2023 to 2030 |
| Base Year | 2022 |
| Forecast Period | 2023-2030 |
| Historical Data | 2020-2021 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • by Facility of Use (Homecare setting, Hospitals, Burn Centres) • by Solids(Suppositories) • by Liquids(Solutions), Transdermal products) • by Route(Dermal, Ophthalmic) • by Type (Semi-solids (Creams, Gels, Lotions) |
| Regional Analysis/Coverage | North America (USA, Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Netherlands, Rest of Europe), Asia-Pacific (Japan, South Korea, China, India, Australia, Rest of Asia-Pacific), The Middle East & Africa (Israel, UAE, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | Valeant Pharmaceuticals International, Inc., Crescita Therapeutics Inc., MedPharm Group Ltd., 3M Company, Bayer AG, Novartis AG, Janssen Global Services, LLC, and Cipla, Galderma S.A., GlaxoSmithKline plc. |
| Key Drivers | • Transdermal patches are replacing traditional needle injections. |
| RESTRAINTS | • Topical medicines cause chronic skin irritation and allergies. • Preference for alternate drug delivery methods. |
Ans: The market share of the Topical Drug Delivery Market in 2023 is US$ 210.03 Billion.
Ans: The CAGR of the Topical Drug Delivery Market is 10.62% over the forecast period 2024-2032.
Ans: The major players in the market are Valeant Pharmaceuticals International, Inc., Crescita Therapeutics Inc., MedPharm Group Ltd., 3M Company, Bayer AG, Novartis AG, Janssen Global Services, LLC, and Cipla, Galderma S.A., GlaxoSmithKline plc., and others in the final report.
Ans: North America region is dominating the Topical Drug Delivery Market.
The use of topical prescription medication for dry eye disorders is extremely common.
Transdermal patches are replacing traditional needle injections.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Ukraine- Russia war
4.3 Impact of ongoing Recession
4.3.1 Introduction
4.3.2 Impact on major economies
4.3.2.1 US
4.3.2.2 Canada
4.3.2.3 Germany
4.3.2.4 France
4.3.2.5 United Kingdom
4.3.2.6 China
4.3.2.7 Japan
4.3.2.8 South Korea
4.3.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8.Global Topical Drug Delivery Market, by Product
8.1 Semi-Solid Formulations
8.2 Liquid Formulations
8.3 Solid Formulations
8.4 Transdermal Products
9.Global Topical Drug Delivery Market, by Route of Administration
9.1 Dermal Drug Delivery
9.2 Ophthalmic Drug Delivery
9.3 Rectal Drug Delivery
9.4 Vaginal Drug Delivery
9.5 Nasal Drug Delivery
10.Global Topical Drug Delivery Market, by Facility of Use
10.1 Home Care Settings
10.2 Hospitals & Clinics
10.3 Burn Centers
10.4 Other Facilities
11. Regional Analysis
11.1 Introduction
11.2 North America
11.2.1 USA
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 France
11.3.4 Italy
11.3.5 Spain
11.3.6 The Netherlands
11.3.7 Rest of Europe
11.4 Asia-Pacific
11.4.1 Japan
11.4.2 South Korea
11.4.3 China
11.4.4 India
11.4.5 Australia
11.4.6 Rest of Asia-Pacific
11.5 The Middle East & Africa
11.5.1 Israel
11.5.2 UAE
11.5.3 South Africa
11.5.4 Rest
11.6 Latin America
11.6.1 Brazil
11.6.2 Argentina
11.6.3 Rest of Latin America
12.Company Profiles
12.1 LLC, IDEMIA
12.1.1 Financial
12.1.2 Products/ Services Offered
12.1.3 SWOT Analysis
12.1.4 The SNS view
12.2 L3Harris Technologies Inc.
12.3 Rapiscan Systems
12.4 Smiths Detection Inc.
12.5 Teledyne e2v
12.6 3DX-RAY
12.7 Astrophysics Inc.
12.8 Autoclear
12.9 Leidos
12.10 Nuctech Company Limited
13. Competitive Landscape
13.1 Competitive Benchmarking
13.2 Market Share Analysis
13.3 Recent Developments
14. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Patient Registry Software Market Size was evaluated at USD 16.79 billion in 2023, and is predicted to increase at a CAGR of 9.7% from 2024 to 2031, to reach USD 35.23 billion by 2031.
The Oral Care Market Size was valued at USD 37.42 billion in 2023 and is expected to reach USD 67.05 billion by 2032, growing at a CAGR of 6.72% over the forecast period 2024-2032.
The Biopharmaceutical CMO Market size was valued at USD 15.3 billion in 2023 and is expected to reach USD 58.2 billion by 2032 with a growing CAGR of 16% over the forecast period of 2024-2031.
The Microservices in Healthcare Market Size was valued at USD 344 million in 2023 and is expected to reach USD 1601.69 million by 2031 and grow at a CAGR of 21.2% over the forecast period 2024-2031.
The Mononucleosis Diagnostic Market size was estimated at USD 1.7 billion in 2022 and is expected to reach USD 3.2 billion by 2030 with a growing CAGR of 8.6% during the forecast period of 2023-2030.
The Peptide Microarray Market size was estimated at USD 830.83 million in 2023 and is expected to reach USD 1245.37 million by 2032 with a growing CAGR of 4.6% during the forecast period of 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
